ALSERES PHARMACEUTICALS INC has a total of 21 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and engines, pumps and turbines are TERRASSE GAETAN, LEUKOS BIOTECH S L and PRIMUS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 3 | |
#5 | Japan | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Engines, pumps and turbines | |
#4 | Medical technology | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Energy from radioactive sources | |
#4 | Heterocyclic compounds | |
#5 | Diagnosis and surgery | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hurtt Mark | 9 |
#2 | Sterzinger Chris | 7 |
#3 | Ferreira Cara | 7 |
#4 | Leyh David | 5 |
#5 | Cusack Noel James | 4 |
#6 | Thorn Richard | 2 |
#7 | Hurtt Mark R | 2 |
#8 | Thorn Richard M | 2 |
#9 | Lay David | 2 |
#10 | Munzer Jon Scott | 2 |
Publication | Filing date | Title |
---|---|---|
WO2009111781A2 | Chimeric c3-like rho antagonist bone therapeutic | |
WO2009111264A2 | Systemic purine administration:modulating axonal outgrowth of central nervous system neurons | |
CA2704104A1 | Labeled iodinated tropane formulation | |
CA2703563A1 | Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level | |
CA2700468A1 | Methods for imaging dopamine transporter level | |
WO2009055421A1 | Chimeric c3-like rho antagonist cardiac therapeutic |